149 related articles for article (PubMed ID: 20193400)
1. [Expression of Survivin protein in extrahepatic cholangiocarcinoma and its relationship with the prognosis].
Qin XL; Xue HZ; Wang ZR; Liu HS; Zhou HB; Ma W
Zhonghua Wai Ke Za Zhi; 2009 Dec; 47(24):1852-6. PubMed ID: 20193400
[TBL] [Abstract][Full Text] [Related]
2. [Detection of lymph node micrometastasis for patients with extrahepatic cholangiocarcinoma and its prognostic significance].
Qin XL; Xue HZ; Wang ZR; Liu HS; Zhou HB; Ma W
Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(10):678-82. PubMed ID: 20450726
[TBL] [Abstract][Full Text] [Related]
3. Expression of Lamininγ2 in extrahepatic cholangiocarcinoma tissues and its influence on tumor invasion and metastasis.
Li Y; Li DJ; Chen J; Liu W; Li JW; Jiang P; Zhao X; Guo F; Li XW; Wang SG
Asian Pac J Cancer Prev; 2015; 16(5):2099-102. PubMed ID: 25773857
[TBL] [Abstract][Full Text] [Related]
4. Expression of LAPTM4B-35: a novel marker of progression, invasiveness and poor prognosis of extrahepatic cholangiocarcinoma.
Zhou L; He XD; Cui QC; Zhou WX; Qu Q; Zhou RL; Rui JA; Yu JC
Cancer Lett; 2008 Jun; 264(2):209-17. PubMed ID: 18334282
[TBL] [Abstract][Full Text] [Related]
5. Negative Expression of DSG1 and DSG2, as Prognostic Biomarkers, Impacts on the Overall Survival in Patients with Extrahepatic Cholangiocarcinoma.
Xu S; Huang S; Li D; Zou Q; Yuan Y; Yang Z
Anal Cell Pathol (Amst); 2020; 2020():9831646. PubMed ID: 32850288
[TBL] [Abstract][Full Text] [Related]
6. Human G-protein gamma 7 in extrahepatic cholangiocarcinoma and its clinicopathological significance.
Wang M; Gong B; Li Y; Wang Y
Hematol Oncol Stem Cell Ther; 2010; 3(2):66-70. PubMed ID: 20543539
[TBL] [Abstract][Full Text] [Related]
7. [Biopathological characteristics of hilar cholangiocarcinoma and the clinical significance].
Yu WL; Zhang YJ; Dong H; Yu H; Xian ZH; Wu MC; Cong WM
Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(15):1162-6. PubMed ID: 20021908
[TBL] [Abstract][Full Text] [Related]
8. Forkhead box protein C2 contributes to invasion and metastasis of extrahepatic cholangiocarcinoma, resulting in a poor prognosis.
Watanabe A; Suzuki H; Yokobori T; Altan B; Kubo N; Araki K; Wada S; Mochida Y; Sasaki S; Kashiwabara K; Hosouchi Y; Kuwano H
Cancer Sci; 2013 Nov; 104(11):1427-32. PubMed ID: 23919841
[TBL] [Abstract][Full Text] [Related]
9. Identification of hepatoma-derived growth factor as a potential prognostic and diagnostic marker for extrahepatic cholangiocarcinoma.
Han Y; Zhang W; Liu Y
World J Surg; 2013 Oct; 37(10):2419-27. PubMed ID: 23793608
[TBL] [Abstract][Full Text] [Related]
10. BIRC7 and STC2 Expression Are Associated With Tumorigenesis and Poor Outcome in Extrahepatic Cholangiocarcinoma.
Li J; Yang Z; Huang S; Li D
Technol Cancer Res Treat; 2020; 19():1533033820971676. PubMed ID: 33234031
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of cystathionine beta-synthase and chemokine ligand 21 is closely associated with poor prognosis in extrahepatic cholangiocarcinoma.
Wang L; Yang Z; Wu Z; He J; Xu S; Li D; Zou Q; Yuan Y
Medicine (Baltimore); 2020 Sep; 99(38):e22255. PubMed ID: 32957374
[TBL] [Abstract][Full Text] [Related]
12. Nerve Growth Factor Expression Is Not Associated with Perineural Invasion in Extrahepatic Cholangiocarcinoma.
Urabe K; Murakami Y; Kondo N; Uemura K; Hashimoto Y; Nakagawa N; Sasaki H; Hiyama E; Takahashi S; Sueda T
Dig Dis Sci; 2016 Mar; 61(3):774-84. PubMed ID: 26547754
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma.
Miyamoto M; Ojima H; Iwasaki M; Shimizu H; Kokubu A; Hiraoka N; Kosuge T; Yoshikawa D; Kono T; Furukawa H; Shibata T
Br J Cancer; 2011 Jun; 105(1):131-8. PubMed ID: 21673683
[TBL] [Abstract][Full Text] [Related]
14. The expressions of HMGA2 and Thy1 in extrahepatic cholangiocarcinoma and their clinicopathological significances.
Liu R; Yang Z; Huang S; Li D; Zou Q; Yuan Y
Surg Oncol; 2019 Jun; 29():41-47. PubMed ID: 31196492
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Impact of Paraaortic Lymph Node Metastasis in Extrahepatic Cholangiocarcinoma.
Nitta N; Ohgi K; Sugiura T; Okamura Y; Ito T; Yamamoto Y; Ashida R; Otsuka S; Sasaki K; Uesaka K
World J Surg; 2021 Feb; 45(2):581-589. PubMed ID: 33079246
[TBL] [Abstract][Full Text] [Related]
16. Correlation of aPKC-iota and E-cadherin expression with invasion and prognosis of cholangiocarcinoma.
Li Q; Wang JM; Liu C; Xiao BL; Lu JX; Zou SQ
Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):70-5. PubMed ID: 18234642
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with otherwise node-negative hilar cholangiocarcinoma.
Tojima Y; Nagino M; Ebata T; Uesaka K; Kamiya J; Nimura Y
Ann Surg; 2003 Feb; 237(2):201-7. PubMed ID: 12560778
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of epithelial-mesenchymal transition-related markers in extrahepatic cholangiocarcinoma: comprehensive immunohistochemical study using a tissue microarray.
Nitta T; Mitsuhashi T; Hatanaka Y; Miyamoto M; Oba K; Tsuchikawa T; Suzuki Y; Hatanaka KC; Hirano S; Matsuno Y
Br J Cancer; 2014 Sep; 111(7):1363-72. PubMed ID: 25077440
[TBL] [Abstract][Full Text] [Related]
19. [Correlation between clinicopathological features and CA19-9/CEA in patients with extrahepatic cholangiocarcinoma].
Tang X; Zhang J; Chen Y; Lan Z; Wang C
Zhonghua Zhong Liu Za Zhi; 2014 Sep; 36(9):662-6. PubMed ID: 25564055
[TBL] [Abstract][Full Text] [Related]
20. DJ-1 is a useful biomarker for invasive extrahepatic cholangiocarcinoma.
Tabata Y; Nakanishi Y; Hatanaka KC; Hatanaka Y; Tsuchikawa T; Okamura K; Noji T; Shichinohe T; Matsuno Y; Hirano S
Hum Pathol; 2018 Jun; 76():28-36. PubMed ID: 29447925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
